This study shows that EPO has no difference in the reduction in the severity of pain in women with mastalgia compared to placebo, topical NSAIDS, danazol, or vitamin E. The number of patients who achieved pain relief was no different compared to the placebo or other treatments. The gene discussed is EPO; the disease is mastodynia.